NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from NovaPeptide? Mail in a sample (US only) and let us test it.

Test my supply
+7 more ↓
67%
Finnrick rating
#343 of 489 ranked vendors
15 of 23 classifiable tests passed
methodology · Purity focus
Finnrick analysis

NovaPeptide's Purity focus record is strongest on Retatrutide, with repeated high-purity identity passes and fills close to target across the observed lots. Evidence is narrow rather than dispersed: only Retatrutide is rated, and thin batch documentation keeps the otherwise recent clean streak evidence-limited.

methodology →
vendor intelligence report
Vendor Intelligence Report: NovaPeptide

Two sister domains tell conflicting China-manufacturer and Delaware-biotech stories, while registry and WHOIS records point elsewhere. The report traces the virtual-office address, informal payment rails, and copycat coupon-page confusion buyers must verify.

18 pages5 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutide
$0.73
85%
12
2
Tirzepatide
$2.50
80%
2
3
GHK-Cu
$0.05
78%
3
4
BPC-157
$0.64
48%
3
5
Tesamorelin
$1.40
41%
3
6
CJC-1295
$1.50
-
0
7
CJC-IPA
$0.99
-
0
8
Glutathione
$0.02
-
0
9
hCG
-
-
0
10
HGH
-
-
0
11
Ipamorelin
$0.65
-
0
12
KLOW
$0.25
-
0
13
NAD+
-
-
0
15
TB-500
$1.02
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%19 Mar 2026: 80%19 Mar 2026: 81%26 Apr 2026: 82%28 Apr 2026: 83%18 Aug 2026: 83%18 Aug 2026: 84%15 Sep 2026: 83%16 Sep 2026: 71%16 Sep 2026: 69%20 Sep 2026: 69%21 Sep 2026: 63%21 Sep 2026: 66%23 Sep 2026: 66%24 Sep 2026: 67%24 Sep 2026: 67%29 Sep 2026: 66%5 Oct 2026: 66%6 Oct 2026: 66%7 Oct 2026: 66%12 Oct 2026: 67%12 Oct 2026: 66%12 Oct 2026: 67%20 Oct 2026: 67%23 Oct 2026: current 67%80%67%Mar 26Oct 26
Free peptide testing

Ordered peptides from NovaPeptide? Mail in a sample (US only) and let us test it.

Test my supply
NovaPeptide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
20 Oct 2026
Pass
Tirzepatide
lab nameView COA
12 Oct 2026
Fail
Tesamorelin
lab nameView COA
12 Oct 2026
Pass
BPC-157
lab nameView COA
12 Oct 2026
Pass
Retatrutide
lab nameView COA
7 Oct 2026
Fail
Tesamorelin
lab nameView COA
6 Oct 2026
Pass
Retatrutide
lab nameView COA
5 Oct 2026
Pass
Retatrutide
lab nameView COA
29 Sep 2026
Fail
GHK-Cu
lab nameView COA
24 Sep 2026
Pass
Retatrutide
lab nameView COA
24 Sep 2026
Pass
GHK-Cu
lab nameView COA
1-10 of 23

About NovaPeptide test results from Finnrick

NovaPeptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 5 peptides and 23 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible NovaPeptide peptides in this dataset are BPC-157 (3 tests), GHK-Cu (3 tests) and Retatrutide (12 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 23 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered peptides from NovaPeptide? Mail in a sample (US only) and let us test it.

Test my supply